<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="23/05/2006" creator="Junko Matsuura" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8690900">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>8690900</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Protein_molecule" id="T1" lex="IL-10">IL-10</term> inhibits <term sem="Other" id="T2" lex="nuclear_factor-kappa_B/Rel_nuclear_activity"><term sem="Protein_complex" id="T3" lex="nuclear_factor-kappa_B/Rel">nuclear factor-kappa B/Rel</term> nuclear activity</term> in <term sem="Cell_cultured" id="T4" lex="CD3-stimulated_human_peripheral_T_lymphocyte"><term sem="Protein_molecule" id="A21">CD3</term>-stimulated <term sem="Cell_natural" id="A22">human peripheral T lymphocytes</term></term>.</sentence>
<event id="E1">
<type class="Negative_regulation" />
<theme idref="T2" />
<cause idref="T1" />
<clue>IL-10 <clueType>inhibits</clueType> nuclear factor-kappa B/Rel nuclear activity <clueLoc>in CD3-stimulated human peripheral T lymphocytes.</clueLoc></clue>
</event>
<event id="E51">
<type class="Physiological_process" />
<theme idref="A22" />
<cause idref="A21" />
<clue>IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-<clueType>stimulated</clueType> human peripheral T lymphocytes.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Protein_molecule" id="T5" lex="IL-10">IL-10</term> markedly reduces nuclear factor <term sem="Other" id="T6" lex="(NF)-kappa_B/Rel_nuclear_activity"><term sem="Protein_complex" id="T7" lex="(NF)-kappa_B/Rel">(NF)-kappa B/Rel</term> nuclear activity</term> induced in <term sem="Cell_natural" id="T8" lex="PBMC">PBMC</term> by stimulation with the <term sem="Protein_family_or_group" id="T9" lex="anti-CD3_mAb">anti-CD3 mAb</term> <term sem="Protein_molecule" id="T10" lex="OKT3">OKT3</term>.</sentence>
<event id="E2">
<type class="Positive_regulation" />
<theme idref="T6" />
<cause idref="T10" />
<clue>IL-10 markedly reduces nuclear factor (NF)-kappa B/Rel nuclear activity <clueType>induced</clueType> <clueLoc>in PBMC</clueLoc> <linkCause>by</linkCause> stimulation with the anti-CD3 mAb OKT3.</clue>
</event>
<event id="E3">
<type class="Negative_regulation" />
<theme idref="E2" />
<cause idref="T5" />
<clue>IL-10 markedly <clueType>reduces</clueType> nuclear factor (NF)-kappa B/Rel nuclear activity induced in PBMC by stimulation with the anti-CD3 mAb OKT3.</clue>
</event>
<sentence id="S3">The inhibition is exerted specifically on the <term sem="Other" id="T11" lex="NF-kappa_B/Rel_activation"><term sem="Protein_complex" id="T12" lex="NF-kappa_B/Rel">NF-kappa B/Rel</term> activation</term> induced by <term sem="Protein_molecule" id="T13" lex="mAb_OKT3">mAb <term sem="Protein_molecule" id="T14" lex="OKT3">OKT3</term></term>, and not that produced by <term sem="Organic_compound_other" id="T15" lex="PMA">PMA</term>.</sentence>
<event id="E4">
<type class="Positive_regulation" />
<theme idref="T12" />
<cause idref="T13" />
<clue>The inhibition is exerted specifically on the NF-kappa B/Rel <clueType>activation</clueType> induced <linkCause>by</linkCause> mAb OKT3, and not that produced by PMA.</clue>
</event>
<event id="E5">
<type class="Positive_regulation" />
<theme idref="T12" />
<cause idref="T15" />
<clue>The inhibition is exerted specifically on the NF-kappa B/Rel <clueType>activation</clueType> induced by mAb OKT3, and not that produced <linkCause>by</linkCause> PMA.</clue>
</event>
<event id="E6">
<type class="Negative_regulation" />
<theme idref="E4" />
<cause idref="T5" />
<clue>The <clueType>inhibition</clueType> is exerted specifically on the NF-kappa B/Rel activation induced by mAb OKT3, and not that produced by PMA.</clue>
<comment>NO COREFCAUSE</comment>
</event>
<event assertion="non-exist" id="E7">
<type class="Negative_regulation" />
<theme idref="E5" />
<cause idref="T5" />
<clue>The <clueType>inhibition</clueType> is exerted specifically on the NF-kappa B/Rel activation induced by mAb OKT3, and not that produced by PMA.</clue>
<comment>NO COREFCAUSE</comment>
</event>
<sentence id="S4">As judged by supershifting the <term sem="Protein_complex" id="T16" lex="DNA-protein_complex">DNA-protein complexes</term> with <term sem="Protein_family_or_group" id="T17" lex="Abs">Abs</term> recognizing specific components of the <term sem="Protein_family_or_group" id="T18" lex="NF-kappa_B/Rel_protein_family"><term sem="Protein_complex" id="T19" lex="NF-kappa_B/Rel">NF-kappa B/Rel</term> protein family</term>, the <term sem="Protein_complex" id="T20" lex="p50/p65">p50/p65</term> (<term sem="Protein_complex" id="T21" lex="Rel_A">Rel A</term>) heterodimeric form of <term sem="Protein_complex" id="T22" lex="NF-kappa_B">NF-kappa B</term> is primarily affected.</sentence>
<event id="E8">
<type class="Negative_regulation" />
<theme idref="T20" />
<clue><clueExperiment>As judged by supershifting the DNA-protein complexes with Abs recognizing specific components of the NF-kappa B/Rel protein family,</clueExperiment> the p50/p65 (Rel A) heterodimeric form of NF-kappa B is primarily <clueType>affected</clueType>.</clue>
</event>
<sentence id="S5">The maximal effect is observed at the <term sem="Other" id="T23" lex="IL-10_concentration"><term sem="Protein_molecule" id="T24" lex="IL-10">IL-10</term> concentration</term> of 20 U/ml.</sentence>
<sentence id="S6"><term sem="Protein_molecule" id="T25" lex="IL-10">IL-10</term> inhibitory activity is exerted on <term sem="Cell_natural" id="T26" lex="T_lymphocyte">T lymphocytes</term> and is mediated by <term sem="Cell_natural" id="T27" lex="monocyte">monocytes</term>.</sentence>
<event id="E9">
<type class="Negative_regulation" />
<cause idref="T25" />
<clue>IL-10 <clueType>inhibitory activity</clueType> is exerted <clueLoc>on T lymphocytes</clueLoc> and is mediated by monocytes.</clue>
</event>
<event id="E10">
<type class="Positive_regulation" />
<theme idref="E9" />
<cause idref="T27" />
<clue>IL-10 inhibitory activity is exerted on T lymphocytes and is <clueType>mediated</clueType> <linkCause>by</linkCause> monocytes.</clue>
</event>
<sentence id="S7">Indeed, <term sem="Cell_natural" id="T28" lex="monocyte">monocytes</term> pretreated with <term sem="Protein_molecule" id="T29" lex="IL-10">IL-10</term> are able so inhibit <term sem="Protein_complex" id="T30" lex="NF-kappa_B">NF-kappa B</term> nuclear activity in purified <term sem="Cell_natural" id="T31" lex="T_lymphocyte">T lymphocytes</term> stimulated with <term sem="Protein_molecule" id="T32" lex="OKT3">OKT3</term>.</sentence>
<event id="E11">
<type class="Artificial_process" />
<theme idref="T28" />
<theme idref="T29" />
<clue>Indeed, monocytes <clueType>pretreated</clueType> <linkTheme>with</linkTheme> IL-10 are able so inhibit NF-kappa B nuclear activity in purified T lymphocytes stimulated with OKT3.</clue>
</event>
<event id="E12">
<type class="Physiological_process" />
<theme idref="T31" />
<theme idref="T32" />
<clue>Indeed, monocytes pretreated with IL-10 are able so inhibit NF-kappa B nuclear activity in purified T lymphocytes <clueType>stimulated</clueType> <linkTheme>with</linkTheme> OKT3.</clue>
</event>
<event id="E13">
<type class="Negative_regulation" />
<theme idref="T30" />
<cause idref="E11" />
<clue>Indeed, monocytes pretreated with IL-10 are able so <clueType>inhibit</clueType> NF-kappa B nuclear activity <clueLoc>in purified T lymphocytes stimulated with OKT3.</clueLoc></clue>
</event>
<sentence id="S8"><term sem="Other" id="A2">Soluble factors</term> do not appear to be involved in the mechanism of inhibition.</sentence>
<event assertion="non-exist" uncertainty="probable" id="E14">
<type class="Correlation" />
<theme idref="A2" />
<theme idref="E13" />
<clue>Soluble factors do not appear to be <clueType>involved</clueType> <linkTheme>in</linkTheme> the mechanism of <corefTheme idref1="E13">inhibition</corefTheme>.</clue>
</event>
<sentence id="S9">On the other hand, the up-regulation of <term sem="Protein_molecule" id="T33" lex="CD80_Ag">CD80 Ag</term>, found on <term sem="Cell_natural" id="T34" lex="monocyte">monocytes</term> obtained from <term sem="Cell_natural" id="T35" lex="PBMC">PBMC</term> incubated with <term sem="Protein_molecule" id="T36" lex="OKT3">OKT3</term>, is not detected after addition of <term sem="Protein_molecule" id="T37" lex="IL-10">IL-10</term>, and the <term sem="Protein_family_or_group" id="T38" lex="anti-CD28_mAb">anti-CD28 mAb</term> <term sem="Protein_molecule" id="T39" lex="CLB-CD28/1">CLB-CD28/1</term> restores the <term sem="Element" id="T40" lex="NF-kappa_B/Rel_nuclear_activity"><term sem="Protein_complex" id="T41" lex="NF-kappa_B/Rel">NF-kappa B/Rel</term> nuclear activity</term> in <term sem="Cell_cultured" id="T42" lex="IL-10-inhibited_lymphocyte"><term sem="Protein_molecule" id="T43" lex="IL-10">IL-10</term>-inhibited <term sem="Cell_natural" id="A23">lymphocytes</term></term>.</sentence>
<event id="E52">
<type class="Artificial_process" />
<theme idref="T36" />
<theme idref="T35" />
<clue>On the other hand, the up-regulation of CD80 Ag, found on monocytes obtained from PBMC <clueType>incubated</clueType> <linkTheme>with</linkTheme> OKT3, is not detected after addition of IL-10, and the anti-CD28 mAb CLB-CD28/1 restores the NF-kappa B/Rel nuclear activity in IL-10-inhibited lymphocytes.</clue>
</event>
<event id="E15">
<type class="Positive_regulation" />
<theme idref="T33" />
<cause idref="E52" />
<clue>On the other hand, the <clueType>up-regulation</clueType> <linkTheme>of</linkTheme> CD80 Ag, found <clueLoc>on monocytes obtained from PBMC</clueLoc> incubated with OKT3, is not detected after addition of IL-10, and the anti-CD28 mAb CLB-CD28/1 restores the NF-kappa B/Rel nuclear activity in IL-10-inhibited lymphocytes.</clue>
</event>
<event assertion="non-exist" id="E16">
<type class="Positive_regulation" />
<theme idref="E15" />
<cause idref="T37" />
<clue>On the other hand, the up-regulation of CD80 Ag, found on monocytes obtained from PBMC incubated with OKT3, is not <clueType>detected</clueType> <linkCause>after</linkCause> addition of IL-10, and the anti-CD28 mAb CLB-CD28/1 restores the NF-kappa B/Rel nuclear activity in IL-10-inhibited lymphocytes.</clue>
</event>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="T41" />
<cause idref="T39" />
<clue>On the other hand, the up-regulation of CD80 Ag, found on monocytes obtained from PBMC incubated with OKT3, is not detected after addition of IL-10, and the anti-CD28 mAb CLB-CD28/1 <clueType>restores</clueType> the NF-kappa B/Rel nuclear activity <clueLoc>in IL-10-inhibited lymphocytes</clueLoc>.</clue>
</event>
<event id="E53">
<type class="Negative_regulation" />
<theme idref="A23" />
<cause idref="T43" />
<clue>On the other hand, the up-regulation of CD80 Ag, found on monocytes obtained from PBMC incubated with OKT3, is not detected after addition of IL-10, and the anti-CD28 mAb CLB-CD28/1 restores the NF-kappa B/Rel nuclear activity in IL-10-<clueType>inhibited</clueType> lymphocytes.</clue>
</event>
<sentence id="S10">Therefore, the <term sem="Protein_complex" id="T44" lex="NF-kappa_B/Rel">NF-kappa B/Rel</term> inhibition might be ascribed to a lack of cooperation between <term sem="Cell_natural" id="A3">accessory cells</term> and <term sem="Cell_natural" id="T45" lex="T_lymphocyte">T lymphocytes</term>, resulting from down-regulation of a costimulatory molecule, such as <term sem="Protein_molecule" id="T46" lex="CD80">CD80</term>, produced by <term sem="Protein_molecule" id="T47" lex="IL-10">IL-10</term> on activated <term sem="Cell_natural" id="T48" lex="monocyte">monocytes</term>.</sentence>
<event id="E18">
<type class="Negative_regulation" />
<theme idref="T44" />
<clue>Therefore, the NF-kappa B/Rel <clueType>inhibition</clueType> might be ascribed to a lack of cooperation between accessory cells and T lymphocytes, resulting from down-regulation of a costimulatory molecule, such as CD80, produced by IL-10 on activated monocytes.</clue>
</event>
<event id="E19">
<type class="Negative_regulation" />
<theme idref="T46" />
<cause idref="T47" />
<clue>Therefore, the NF-kappa B/Rel inhibition might be ascribed to a lack of cooperation between accessory cells and T lymphocytes, resulting from <clueType>down-regulation</clueType> <linkTheme>of</linkTheme> a <corefTheme>costimulatory molecule</corefTheme>, such as CD80, produced <linkCause>by</linkCause> IL-10 <clueLoc>on activated monocytes</clueLoc>.</clue>
</event>
<event id="E20">
<type class="Cell_communication" />
<theme idref="A3" />
<theme idref="T45" />
<clue>Therefore, the NF-kappa B/Rel inhibition might be ascribed to a lack of <clueType>cooperation</clueType> <linkTheme>between</linkTheme> accessory cells and T lymphocytes, resulting from down-regulation of a costimulatory molecule, such as CD80, produced by IL-10 on activated monocytes.</clue>
</event>
<event id="E22">
<type class="Negative_regulation" />
<theme idref="E20" />
<cause idref="E19" />
<clue>Therefore, the NF-kappa B/Rel inhibition might be ascribed to a <clueType>lack</clueType> <linkTheme>of</linkTheme> cooperation between accessory cells and T lymphocytes, <linkCause>resulting from</linkCause> down-regulation of a costimulatory molecule, such as CD80, produced by IL-10 on activated monocytes.</clue>
</event>
<event uncertainty="probable" id="E23">
<type class="Positive_regulation" />
<theme idref="E18" />
<cause idref="E22" />
<clue>Therefore, the NF-kappa B/Rel inhibition might be <clueType>ascribed</clueType> <linkTheme>to</linkTheme> a lack of cooperation between accessory cells and T lymphocytes, resulting from down-regulation of a costimulatory molecule, such as CD80, produced by IL-10 on activated monocytes.</clue>
</event>
<event id="E54">
<type class="Physiological_process" />
<theme idref="T48" />
<clue>Therefore, the NF-kappa B/Rel inhibition might be ascribed to a lack of cooperation between accessory cells and T lymphocytes, resulting from down-regulation of a costimulatory molecule, such as CD80, produced by IL-10 on <clueType>activated</clueType> monocytes.</clue>
</event>
<sentence id="S11">Our results demonstrate that <term sem="Protein_molecule" id="T49" lex="IL-10">IL-10</term> can inhibit the induction of <term sem="Protein_complex" id="T50" lex="NF-kappa_B/Rel">NF-kappa B/Rel</term> nuclear activity in <term sem="Cell_cultured" id="T51" lex="CD3-stimulated_T_lymphocyte"><term sem="Protein_molecule" id="A25">CD3</term>-stimulated <term sem="Cell_natural" id="T52" lex="T_lymphocyte">T lymphocytes</term></term>.</sentence>
<event id="E24">
<type class="Positive_regulation" />
<theme idref="T50" />
<clue>Our results demonstrate that IL-10 can inhibit the <clueType>induction</clueType> <linkTheme>of</linkTheme> NF-kappa B/Rel nuclear activity <clueLoc>in CD3-stimulated T lymphocytes</clueLoc>.</clue>
</event>
<event id="E25">
<type class="Negative_regulation" />
<theme idref="E24" />
<cause idref="T49" />
<clue>Our results demonstrate that IL-10 can <clueType>inhibit</clueType> the induction of NF-kappa B/Rel nuclear activity in CD3-stimulated T lymphocytes.</clue>
</event>
<event id="E55">
<type class="Physiological_process" />
<theme idref="T52" />
<cause idref="A25" />
<clue>Our results demonstrate that IL-10 can inhibit the induction of NF-kappa B/Rel nuclear activity in CD3-<clueType>stimulated</clueType> T lymphocytes.</clue>
</event>
<sentence id="S12">Since inappropriate activation of <term sem="DNA_family_or_group" id="T53" lex="kappa_B-driven_gene">kappa B-driven genes</term> has a physiopathologic role in a number of diseases, such as <term sem="Other" id="T54" lex="HIV_infection"><term sem="Virus" id="A26">HIV</term> infection</term>, our findings support the possibility of using this cytokine to suppress an undesirable activation of these <term sem="Protein_family_or_group" id="T55" lex="transcription_factor">transcription factors</term>.</sentence>
<event id="E26">
<type class="Positive_regulation" />
<theme idref="T53" />
<clue>Since <clueType>inappropriate activation</clueType> <linkTheme>of</linkTheme> kappa B-driven genes has a physiopathologic role in a number of diseases, such as HIV infection, our findings support the possibility of using this cytokine to suppress an undesirable activation of these transcription factors.</clue>
</event>
<event id="E28">
<type class="Correlation" />
<theme idref="E26" />
<theme idref="T54" />
<clue>Since inappropriate activation of kappa B-driven genes <clueType>has</clueType> a physiopathologic <clueType>role</clueType> <linkTheme>in</linkTheme> <corefTheme idref1="T54">a number of diseases</corefTheme>, such as HIV infection, our findings support the possibility of using this cytokine to suppress an undesirable activation of these transcription factors.</clue>
</event>
<event id="E29">
<type class="Positive_regulation" />
<theme idref="T50" />
<clue>Since inappropriate activation of kappa B-driven genes has a physiopathologic role in a number of diseases, such as HIV infection, our findings support the possibility of using this cytokine to suppress an undesirable <clueType>activation</clueType> <linkTheme>of</linkTheme> <corefTheme>these transcription factors</corefTheme>.</clue>
</event>
<event id="E30">
<type class="Negative_regulation" />
<theme idref="E29" />
<cause idref="T49" />
<clue>Since inappropriate activation of kappa B-driven genes has a physiopathologic role in a number of diseases, such as HIV infection, our findings support the possibility of using <corefCause>this cytokine</corefCause> to <clueType>suppress</clueType> an undesirable activation of these transcription factors.</clue>
</event>
<event id="E56">
<type class="Initiation_of_viral_infection" />
<theme idref="A26" />
<clue>Since inappropriate activation of kappa B-driven genes has a physiopathologic role in a number of diseases, such as HIV <clueType>infection</clueType>, our findings support the possibility of using this cytokine to suppress an undesirable activation of these transcription factors.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
